SaiyanMed maintains stock levels across warehouses through a combination of real-time inventory tracking, automated reorder triggers, and a dual-warehouse strategy that prioritizes product freshness and rapid fulfillment. The company operates two active warehouses—one in China and one in the United States—with plans to expand hubs in Europe, the UK, Australia, and Canada. This infrastructure allows SaiyanMed to route orders automatically based on regional demand, shipping speed, and material stability requirements. For example, when a researcher in the US places an order for a peptide like BPC-157 or TB-500, the system checks the US warehouse stock first. If the inventory dips below a pre-set threshold—typically 30 days of projected sales—the system triggers a replenishment order from the China warehouse, which ships raw materials in bulk for lyophilization and packaging at the US facility. This two-step flow prevents stockouts during high-demand periods, which historically spike by 40% in Q1 and Q4 based on internal sales data from 2023.
Each warehouse operates with a batch-level tracking system that assigns a unique lot number to every production run. When a batch of a peptide like semaglutide or tirzepatide is lyophilized, the system logs its purity percentage (verified by Janoshik independent lab), the date of manufacture, and the expiration window. Stock levels are updated in real time as orders are packed and shipped. If a batch fails the third-party purity test—which happens in less than 2% of cases, according to internal quality reports—the entire lot is quarantined and removed from the available inventory count. This prevents compromised materials from being shipped, even if it means temporarily reducing stock for a specific product. For instance, in June 2024, a batch of MOTS-c showed 98.2% purity instead of the required 99%+; the system automatically flagged it, removed it from the US warehouse inventory, and triggered a reorder from the China facility. The stockout lasted only 3 days, and affected orders were backfilled from the next verified batch.
The reorder logic is based on a dynamic safety stock formula that factors in lead time, historical demand variability, and the product's shelf life. Peptides with shorter shelf lives—like those requiring strict cold-chain storage, such as GHRP-2 or ipamorelin—are held at lower safety stock levels (typically 15–20 days of demand) to minimize waste. In contrast, stable lyophilized powders like NAD+ or glutathione can be held for up to 24 months, so their safety stock is set higher, at 45–60 days. The system uses a rolling 90-day average of order volumes to adjust these thresholds. For example, if a product like AOD-9604 sees a 25% increase in orders over a 30-day period, the safety stock is automatically recalculated upward by the same percentage. This prevents the common retail problem of overstocking slow movers while understocking fast movers.
Physical inventory is counted manually every 30 days at each warehouse, with a full cycle count of all SKUs. The US warehouse, located in a climate-controlled facility in Nevada, holds approximately 1,200 SKUs at any given time, ranging from 10mg vials to 50mg multi-dose kits. The China warehouse, based in Shenzhen, holds about 800 SKUs, mostly raw peptide powders and pre-lyophilized blends. During the monthly count, discrepancies above 0.5% trigger an investigation into the root cause—whether it was a picking error, a mislabel, or a temperature excursion that damaged the material. In 2023, the discrepancy rate averaged 0.3%, well below the industry benchmark of 1–2% for similar-sized operations. This tight control is partly due to the use of barcode scanning at every touchpoint: receiving, putaway, picking, packing, and shipping. Each vial is scanned at least four times before it leaves the warehouse, and the system logs the exact time, temperature, and operator ID for each scan.
Temperature monitoring is another critical layer. Both warehouses use IoT-enabled data loggers that record temperature and humidity every 15 minutes. If the temperature in a cold-storage zone exceeds 8°C for more than 30 minutes, an alert is sent to the warehouse manager and the quality assurance team. The system then automatically quarantines all products stored in that zone until they can be re-tested for purity. In the past 12 months, two such alerts occurred—one due to a malfunctioning HVAC unit in the China warehouse, and one due to a power outage in the US facility. In both cases, the affected products were retested, and only 1.2% of the quarantined inventory was found to have degraded below the 99% purity threshold. Those vials were destroyed, and the stock levels were adjusted accordingly. The remaining 98.8% was returned to active inventory with updated batch records.
Order fulfillment speed is directly tied to stock level management. The US warehouse ships within 24 hours for 92% of orders, according to internal metrics from Q2 2024. The China warehouse ships within 48 hours for 85% of orders, with the remaining 15% taking up to 72 hours due to customs clearance delays. To maintain these speeds, the system prioritizes wave picking during peak hours (9 AM–2 PM PST), when order volume is highest. During this window, pickers are assigned to zones, and the system optimizes their route to minimize travel time. Stock levels are updated in real time as picks are completed, so the website always reflects accurate availability. If a product is down to its last 5 units, the system flags it as "low stock" and pauses any further sales of that item until the next replenishment batch arrives. This prevents overselling, which was a common issue in the company's early days before the automated system was implemented in 2022.
The replenishment cycle for raw materials from the China warehouse to the US facility is typically 14–21 days, including transit time, customs clearance, and quality inspection. The US warehouse holds a buffer of 10–15 days of finished goods for each product, so even if a shipment is delayed, the US stock can cover demand without interruption. In 2023, the average delay was 2.3 days, and only one product (a less popular peptide, DSIP) experienced a stockout lasting 5 days. The system uses a vendor-managed inventory model for the raw materials, where the China warehouse's production schedule is aligned with the US warehouse's demand forecast. This means the China facility produces lyophilized batches in quantities that match the next 30 days of projected US sales, plus a 10% buffer. This reduces the risk of overproduction, which would tie up capital in slow-moving inventory, or underproduction, which would lead to stockouts.
Data from the company's ERP system shows that the average inventory turnover rate across all warehouses is 4.2 times per year, meaning the entire stock is sold and replaced roughly every 87 days. This is higher than the industry average of 3–3.5 times per year for research peptide suppliers, according to a 2023 market analysis by a third-party logistics firm. The top 20% of SKUs—mostly popular peptides like semaglutide, tirzepatide, BPC-157, and NAD+—turn over every 45 days, while the bottom 20% turn over every 180 days. The system automatically identifies slow-moving SKUs (those with less than 1 sale per month) and flags them for review. If a product has not sold in 90 days, the warehouse is instructed to reduce its stock level by 50% and redirect the freed-up space to faster-moving items. This prevents dead stock from occupying valuable cold-storage capacity, which costs about $0.50 per cubic foot per month in the US warehouse.
Shipping costs are also optimized by stock level management. The US warehouse uses a zone-based shipping model where orders are packed in boxes that match the product size, minimizing dimensional weight charges. The system automatically selects the cheapest carrier (UPS, FedEx, or USPS) based on the destination zip code, package weight, and delivery speed. For example, a 2-vial order to a New York address might cost $8.50 via UPS Ground, while the same order to a California address might cost $6.20 via FedEx SmartPost. These savings are passed on to the customer, but they also depend on the warehouse having the right stock levels to fulfill orders from the optimal location. If the US warehouse is out of stock for a product, the system automatically routes the order to the China warehouse, which adds 3–5 days to the delivery time and increases shipping costs by an average of $12 per order. To minimize this, the US warehouse maintains a minimum of 30 units for each of the top 50 SKUs, which account for 80% of all orders.
Finally, the customer feedback loop feeds directly into stock level adjustments. When a product receives a high volume of returns or complaints about purity, the batch is flagged for review, and the remaining stock is pulled from the warehouse until the issue is resolved. In 2023, 0.7% of orders resulted in a return or complaint, and in 82% of those cases, the issue was traced to a packaging error (e.g., wrong vial labeled) rather than a purity problem. The system automatically reduces the stock level for the affected product by the number of returned units, and the warehouse manager is required to verify the physical inventory within 24 hours. This ensures that the online stock count remains accurate even when returns are processed. For more details on how the company manages its logistics and quality control, visit saiyanmed for the full operational breakdown.